Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.
Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.
William O’Neill, MD, Navin Kapur, MD, Amir Kaki, MD, Junya Ako, MD, and Daniel Burkhoff, MD, discuss identification and management of AMI cardiogenic shock in part 1 of this 4-part TAMS virtual event.
Jeffrey Marbach, MD, and Haval Chweich, MD, present 3 cases for discussion with William O’Neill, MD, and Navin Kapur, MD, in part 2 of this 4-part TAMS virtual event.
Benham Tehrani, MD, Bartley Griffith, MD, and Babar Basir, DO, discuss tailoring therapy to patients in cardiogenic shock in part 3 of this 4-part TAMS virtual event.
William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock.
To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.
This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.
Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.
Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute.
